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Background: Toxoplasmosis is one of the most common human zoonosis, and is generally benign in most of the
individuals. Pulmonary involvement is common in immunocompromised subjects, but very rare in immunocompetents
and there are scarce reports of tomographic findings in the literature. The aim of the study is to describe three
immunocompetent patients diagnosed with acute pulmonary toxoplasmosis and their respective thoracic
tomographic findings. Acute toxoplasmosis was diagnosed according to the results of serological tests suggestive of
recent primary infection and the absence of an alternative etiology.
Case presentation: From 2009 to 2013, three patients were diagnosed with acute respiratory failure secondary to
acute toxoplasmosis. The patients were two female and one male, and were 38, 56 and 36 years old. Similarly they
presented a two-week febrile illness and progressive dyspnea before admission. Laboratory tests demonstrated
lymphocytosis, slight changes in liver enzymes and high inflammatory markers. Tomographic findings were bilateral
smooth septal and peribronchovascular thickening (100%), ground-glass opacities (100%), atelectasis (33%), random
nodules (33%), lymph node enlargement (33%) and pleural effusion (66%). All the patients improved their symptoms
after treatment, and complete resolution of tomographic findings were found in the followup.
Conclusion: These cases provide a unique description of the presentation and evolution of pulmonary tomographic
manifestations of toxoplasmosis in immunocompetent patients. Toxoplasma pneumonia manifests with fever, dyspnea
and a non-productive cough that may result in respiratory failure. In animal models, changes were described as
interstitial pneumonitis with focal infiltrates of neutrophils that can finally evolve into a pattern of diffuse alveolar
damage with focal necrosis. The tomographic findings are characterized as ground glass opacities, smooth septal and
marked peribronchovascular thickening; and may mimic pulmonary congestion, lymphangitis, atypical pneumonia and
pneumocystosis. This is the largest series of CT findings of acute toxoplasmosis in immunocompetent hosts, and the
diagnosis should be considered as patients that present with acute respiratory failure in the context of a subacute
febrile illness with bilateral and diffuse interstitial infiltrates with marked peribronchovascular thickening. If promptly
treated, pulmonary toxoplasmosis can result in complete clinical and radiological recovery in immunocompetent hosts.
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Toxoplasma gondii is one of the most common human
zoonosis, infecting approximately one-third of the world’s
population [1]. Although rare in Europe and in the USA,
the seroprevalence for this obligate intracellular protozoan
can reach 79% in males and 63% in females in Brazil [2].
Toxoplasmosis is generally benign and often goes un-
noticed in healthy hosts; however, non-specific “flu-like”
symptoms, hepatomegaly and diffuse lymphadenopathy
may be associated with primary infection [2].
In adults, infection can result from the ingestion of
undercooked or raw meat containing tissue cysts or
from the consumption of water or food contaminated by
oocysts that are excreted in the feces of infected cats
[3,4]. Rarely, the parasite is also transmitted by blood
transfusion or organ transplantation [5,6].
Pulmonary involvement in acute toxoplasmosis has
been described in immunosuppressed patients [4-6], but
is rare in immunocompetent subjects [7,8] Herein, we
describe chest computed tomography (CT) findings in
three immunocompetent patients with confirmed acute
T. gondii infection and review the current literature.
Case presentation
From 2009 to 2013, three patients were diagnosed with
acute respiratory failure secondary to acute toxoplasmo-
sis with extensive lung involvement. Two of the patients
were female, and one was male; the patients were 38, 56
and 36 years old, respectively. All three patients similarly
presented to the emergency department with a two-
week febrile illness and progressive dyspnea during the
few days before admission without previous respiratory
symptoms. The physical examinations revealed crackles
in all patients and low oxygen saturation (SpO2) values,
ranging from 82% to 86%. One patient had splenomeg-
aly. Regarding their medical history, two of the patients
had Type 2 diabetes, one of whom had undergone baria-
tric surgery the year prior. The third patient was pre-
viously healthy. Laboratory test results were normal with
the exception of lymphocytosis with atypical lym-
phocytes (in two patients), slight changes in liver en-
zymes and high inflammatory markers. The clinical andTable 1 Clinical and laboratory findings of patients with acut
Patient Age Year of
diagnosis
Gender Medical history Symptoms




2 56 2011 Female Type 2 diabetes Fever and
progressive d
3 38 2009 Female - Fever, cough
dyspnea
*C-reactive protein. **Aspartate aminotransferase. ***Alanine aminotransferase.laboratory findings are summarized in Table 1. One pa-
tient was transferred from another hospital, where she
was submitted to a lung biopsy and pleural drainage; un-
fortunately, we did not have access to these results.
The diagnosis of toxoplasmosis was made from serology
(positive for IgM antibodies and low IgG avidity). In our
institutions, real-time polymerase chain reaction-based
assay to detect DNA of T.gondii is not available; therefore,
serologic (IgM, IgG and IgG avidity) testing is our routine
diagnosis method. All patients were investigated for im-
munodeficiency disorders (primary immunodeficiencies,
hematological and non-hematological malignancies, and
immunoglobulinopathies) and the use of immunosuppres-
sive drugs. Regarding infectious differential diagnosis, all
three patients had negative blood and urine cultures. Ser-
ology was performed for HIV, viral hepatitis (A, B and C),
Epstein-Barr and cytomegalovirus in each one of the
pacients and the results were negative. The lung biopsy
culture, when performed, was negative for all micro-
organisms. Serology for Mycoplasma pneumoniae and
Chlamydia pneumonia was performed in one of the pa-
tients; however, result was negative.
All patients underwent a chest CT scan, and the follow-
ing CT abnormalities were found: bilateral smooth septal
and peribronchovascular thickening (100%), ground-glass
opacities (100%) (Figures 1 and 2), atelectasis (33%) and
random nodules varying in size from 5 m to 2.5 cm (33%).
Mediastinal findings were present in one patient and were
characterized as paratracheal lymph node enlargement.
Bilateral pleural effusions were noted in 2 patients (66%).
The radiological findings are summarized in Table 2.
Follow-up CT scans were obtained from one of the
patients after complete resolution of the symptoms
and demonstrated complete resolution of the findings
(Figure 3A and B), and none of the patients presented
respiratory or extra-pulmonary relapses.
Written informed consent was obtained from each of
the patients regarding clinical and radiological data.
These three cases provide a remarkable description of
the presentation and evolution of pulmonary tomogra-
phic manifestations of toxoplasmosis in immunocompe-









che 13200 7500 (70 atypical) 35 217 314
yspnea
9.800 4.000 12 108 169
and 11.350 6.700 (1.230 atypical) 26 190 229
Figure 1 A 55 year-old female with pulmonary toxoplasmosis.
Axial view of CT scan displays bilateral ground-glass opacities,
interlobular and peribronchovascular smooth thickening and small
bilateral pleural effusion.
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tozoan that belongs to the phylum Apicomplexa and
subclass coccidia. This protozoan can assume three dif-
ferent forms: the oocyst, which releases sporozoites; the
tissue cyst, which contains and may release bradyzoites;
and the tachyzoite, which is a rapidly dividing, prolifera-
tive form of the parasite [1,2]. Felines are the definitive
host, and human infection typically occurs via ingestion
of undercooked meats containing tissue cysts or spo-
rulated oocysts [1,2]. Tachyzoites can infect almost all
nucleated cells in humans, residing and multiplying in
host cells; the most commonly involved organs include
the lymph nodes, brain, retinal cells, heart and lungs [8].Figure 2 A 38-year-old male with pulmonary toxoplasmosis.
Axial view of CT scan displays ground glass opacities and septal
thickening.The dissemination of rapidly dividing tachyzoites to
various tissues represents either an acute infection
(when these tachyzoites circulate via blood or lymphatic
systems potentially infecting all cells and tissues) or the
reactivation of a latent infection [1,2].
The activation of the systemic immune response and/
or antimicrobial therapy is usually sufficient to reduce
the protozoan population, resulting in complete healing
or occasionally a persistent chronic or latent infection
state [2,7].
Acute toxoplasmosis with diffuse systemic and pulmon-
ary involvement is most commonly related to immuno-
compromised patients. In this population, typical clinical
findings include fever, lymph node enlargement, dyspnea
and occasionally myalgia and gastrointestinal symptoms.
The disease is very severe; cases of disseminated toxoplas-
mosis after stem cell transplantation (SCT) reach a mor-
tality rate of 80% with a median survival time of 10 days
post-diagnosis and 62.5 days post-allogeneic SCT [9].
In immunocompetent individuals, severe toxoplasmo-
sis seems to be related to the pathogenicity of the micro-
organism strain. T. gondii strains from South America
have atypical genotypes and higher diversity compared
to the ones formerly described in North America and
Europe. These atypical strains have been associated with
a worse clinical involvement and outcome in mice and
humans, due to its increased pathogenicity [9]. Indeed,
most of the previous reported cases of severe toxoplas-
mosis and lung injury were reported in patients from
these regions, or even patients infected by consumption
of raw horsemeat imported from these regions [10].
In point of fact, lung involvement associated with
T. gondii infection is rather rare in immunocompetent
subjects, with only scarce descriptions in the medical lite-
rature. There are no recognized predisposing factors but,
as discussed above, infections with more virulent strains, a
high parasite burden, or even through inhalation of micro-
organisms are possible explanations [11,12].
Toxoplasma gondii pneumonia manifests with fever,
dyspnea and a non-productive cough. In animal models,
the earliest change following intravenous injection of
infective tachyzoites is an interstitial pneumonitis with
focal infiltrates of neutrophils, eosinophils and mono-
nuclear cells. As the interstitial infiltrate spreads, the ex-
udation of fibrin along with neutrophils and macrophages
into alveolar spaces can occur. This can finally evolve into
a pattern of diffuse alveolar damage with pneumocyte pro-
liferation and focal necrosis [13,14].
Radiological abnormalities have been described in im-
munocompromised patients Chest radiographs demon-
strates a reticulonodular infiltrate as a main finding, but
nodular and coalescence opacities have also been de-
scribed. In these patients, usual CT findings are bilateral
and diffuse interstitial infiltrate with ground glass opacity
Table 2 CT findings of patients diagnosed with pulmonary toxoplasmosis
CT findings Pulmonary Mediastinal Pleural
1 Diffuse GGO opacities, peribronchovascular and
septal thickening, and nodules
- Small bilateral effusion
2 Diffuse GGO opacities and peribronchovascular
and septal thickening
Paratracheal lymph node enlargement
3 Diffuse GGO opacities, peribronchovascular
and septal thickening, and atelectasis
Small bilateral effusion
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that might be indistinguishable from Pneumocystis jirovecii
pneumonia in certain cases [15,16].
In immunocompetent subjects, former reports demon-
strate diffuse interstitial infiltrate [17]. However, the CT
patterns of pulmonary involvement have been poorly de-
scribed in this population. Literature reports demon-
strate diffuse ground-glass opacities with some degree of
interlobular septal thickening and pulmonary nodules,
associated or not to pleural effusion [12,13]. Our fin-
dings corroborate that the most prevalent findings are
parenchymal abnormalities described as ground glass
opacities, smooth septal and marked peribronchovas-
cular thickening; as these findings were evident in all
three patients. Atelectasis and nodules varying in size
from 1.0 to 2.5 cm were also found, as was pleural effu-
sion. Consequently, the main findings may mimic pul-
monary congestion, lymphangitis, atypical pneumonia
and pneumocystosis.
Conclusions
Because pulmonary toxoplasmosis is an uncommon in-
fection, only a very limited number of cases are available
to report in this study. Nevertheless, this is the largest
series of CT findings of acute toxoplasmosis in immuno-
competent hosts, and it raises concern that pulmonaryFigure 3 A 36-year-old male patient with pulmonary toxoplasmosis. A
opacities and smooth septal and peribronchovascular thickening. In figure
was evident.’toxoplasmosis should be considered as a differential
diagnosis in immunocompetent patients that present
with acute respiratory failure in the context of a sub-
acute febrile illness.
Bilateral and diffuse interstitial infiltrates with marked
peribronchovascular thickening with or without pleural
effusion are the main tomographic patterns. Under these
circumstances, a complete clinical history of raw or
undercooked meat consumption or other potential expo-
sures should be explored. If available, search for the spe-
cific strain of T. gondii should be attempted, as more
virulent organisms seem to cause more severe organ
compromise. Specific antimicrobial therapy with com-
bination pyrimethamine, sulfadiazine and folinic acid
should be instituted after a definitive diagnosis or in
highly suspected cases [1,7] because the disease can have
a potentially life-threatening course. If promptly treated,
as demonstrated in the literature and our case series
[5,17], pulmonary toxoplasmosis can result in complete
lung recovery in immunocompetent hosts.
Consent
“Written informed consent was obtained from the pa-
tient for publication of this Case report and any accom-
panying images. A copy of the written consent is
available for review by the Editor of this journal.”xial view of chest CT scan in A displays bilateral ground glass
B, a complete resolution of the findings 3 months after treatment
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